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Research
AbstrACt
Objectives Poisoning is a frequent cause of admission 
to the emergency department (ED) and may involve drugs 
known to prolong the QT interval. This study aims to 
describe the prevalence of QTc prolongation among ED 
patients with suspected poisoning and to calculate the 
absolute and relative risk of mortality or cardiac arrest 
associated with a prolonged QTc interval.
Methods We performed a register-based cohort study, 
including all adult first-time contacts with suspected 
poisoning to the ED of two Swedish hospitals (January 
2010–December 2014) and two Danish hospitals 
(March 2013–April 2014). We used propensity score 
matching to calculate HRs for all-cause mortality or 
cardiac arrest (combined endpoint) within 30 days after 
contact comparing patients with a prolonged QTc interval 
(≥450 ms men, ≥460 ms women) with patients with a QTc 
interval of <440 ms.
results Among all first-time contacts with suspected 
poisoning that had an ECG recorded within 4 hours after 
arrival (n=3869), QTc prolongation occurred in 6.5%. The 
overall mortality after a 30-day follow-up period was 0.8% 
(95% CI 0.6 to 1.2), with an absolute risk of mortality or 
cardiac arrest in patients with QTc prolongation of 3.2% 
(95% CI 1.4 to 6.1). A prolonged QTc interval on arrival 
was associated with a HR of 3.6 (95% CI 1.0 to 12.2).
Conclusion In the ED, a prolonged QTc interval in patients 
arriving with suspected poisoning seems to be associated 
with a threefold increased risk of 30-day all-cause 
mortality or cardiac arrest.
IntrOduCtIOn
Poisoning is a frequent cause of admission 
to the emergency department (ED)1 2 and 
involves a variety of different drugs and 
substances. A wide range of drugs have been 
linked to QTc prolongation,3 which has been 
associated with all-cause mortality, cardio-
vascular death and sudden cardiac death.4–9 
As an increased risk of mortality has been 
documented in patients treated with poten-
tial QTc prolonging drugs,10–13 one may 
hypothesise that the risk is even higher among 
poisoned patients. Therefore, cardiac moni-
toring is recommended in patients poisoned 
by potentially proarrhythmic agents and 
drugs that can lead to torsades de pointes.14 
Only few studies have investigated the 
relationship between QTc prolongation and 
adverse outcomes in a population of undif-
ferentiated poisoned patients.15 16 The abso-
lute and relative risk of mortality and cardiac 
arrest associated to QTc prolongation in 
poisoned patients remains unknown. There-
fore, we aimed to: (1) describe the preva-
lence of QTc prolongation found among 
patients with suspected poisoning in the ED; 
and (2) to investigate if QTc prolongation is 
associated with an increased risk of mortality 
or cardiac arrest within 30 days after arrival 
to the ED.
MAterIAls And MethOds
study design and setting
This is a register-based cohort study. The study 
is based on ED data from 1 January 2010 to 
strengths and limitations of this study
 ► Patients were included from four different hospi-
tals—two Swedish and two Danish.
 ► Propensity score matching was used to adjust for 
several confounders.
 ► Subgroups analysis was not possible due to a small 
number of events.
 ► The included ECGs were all automatic readouts, 
and the length of the QT interval was not confirmed 
manually.
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31 December 2014 from two Swedish hospitals (Skåne 
University Hospital, Lund, and Helsingborg Hospital) 
and from two Danish hospitals (Odense University 
Hospital and the Hospital of South West Jutland, Esbjerg) 
from 1 March 2013 to 30 April 2014. In both Denmark 
and Sweden, the healthcare systems are tax-funded, and 
all residents have free access to healthcare. The University 
Hospital Skåne has a contingency population of approx-
imately 310 000, whereas Odense University Hospital 
covers a population of 290 000 people. The two regional 
hospitals have a contingency population of 250 000 
people (Helsingborg) and 220 000 people (Esbjerg).
selection of participants
We identified all adults (≥18 years) who arrived to the 
EDs with suspected poisoning. The contacts were eligible 
for the main analysis if they had a 12-lead ECG recorded 
within 4 hours after arrival. A missing QTc interval on the 
recorded ECG or a QRS duration of ≥120 ms were both 
reasons for exclusion. Patients with multiple contacts 
were included only at their first contact with suspected 
poisoning within the study period. Information regarding 
identification of patients with suspected poisoning is 
outlined in online supplementary appendix A.
data sources
In both Denmark and Sweden, all residents have a 
unique personal civil registration number, which allows 
cross-linkage at personal level between databases. We 
extracted data from several registries: the logistic systems 
in the ED at the Region of Southern Denmark17 and 
Region of Skåne, the electronic central ECG databases at 
Region of Southern Denmark and Region of Skåne, the 
Danish National Patient Registry18 and Region of Skåne 
Healthcare databases, the Danish National Prescription 
Registry,19 the Swedish Pharmacy Registry,20 and finally 
The Danish Civil Registration System21 and the Swedish 
Population Register.22 Further information regarding 
the data sources is provided in online supplementary 
appendix A.
eCG measurements and definitions
The QT interval was measured at the first ECG recorded 
after contact to the ED. All the QT intervals were calcu-
lated automatically as a median value and stored in either 
MUSE Cardiology Information System (GE Healthcare) 
or Philips Diagnostic ECG. The GE Marquette 12SL 
ECG Analysis Program provided QTc intervals for ECGs 
recoded in MUSE.23 ECGs recorded by Phillips were anal-
ysed by the DXL-algorithm.24 Only QT intervals corrected 
for heart rate (QTc) was used in our analysis. For correc-
tion, we chose the Framingham Formula (QTcFraming-
ham=QT+0.154 (1−RR)).
25 Additional details about ECG 
measurements are outlined in online supplementary 
appendix B.
exposure and outcome
Our primary outcome was a combined endpoint of 
all-cause mortality or cardiac arrest (defined in online 
supplementary appendix C.1) within 30 days from the 
day of arrival to the ED. All patients were followed for 30 
days, including those transferred to another department. 
Patients who died in relation to cardiac arrest were clas-
sified as dead rather than cardiac arrests. The primary 
exposure was QTc prolongation, defined as a QTc 
of ≥450 ms for men and ≥460 ms for women.26 Patients 
with a normal QTc length were defined as having a QTc 
interval of <450 ms (men) or <460 ms (women).
Analysis
The prevalence of QTc prolongation overall and in rela-
tion to specific groups of poisoning was described in a 
cross-sectional description. In this description, we iden-
tified all patients with a discharge diagnosis of poisoning 
(International Classification of Diseases (ICD-10) codes 
T36*-T65*, F100*, F110*, F120*, F130*, F140*, F150*, 
F160*, F170*, F180* or F190* as a primary or secondary 
diagnosis). All patients, who had a discharge diagnosis of 
poisoning, were subdivided into five poisoning groups: 
(1) analgesics and drugs of abuse, (2) psychotropic drugs 
including drugs affecting the central nervous system, (3) 
organic and chemical substances, non-medical, (4) others 
and (5) multidrug (see online supplementary appendix 
C.2).
The association between QTc prolongation and 
all-cause mortality and cardiac arrest was evaluated 
using propensity score matching.27 28 We calculated 
a propensity score for all included patients by use of 
logistic regression with QTc ≥450 ms (men) or ≥460 ms 
(women) as the outcome (binary outcome). Patients 
with a QTc interval between 440–449 ms (men) and 
440–459 ms (women) were excluded in the model to 
avoid near-overlapping ranges. The following possible 
confounders were included in the propensity score 
model: sex, age, comorbidity (measured as Charlson 
Comorbidity Index29 30), history of myocardial infarc-
tion or congestive heart failure (online supplementary 
appendix C.3 and C.4), prescription of QT prolonging 
drugs within 90 days (defined in online supplemen-
tary appendix C.5),31 heart rate and study centre. We 
performed a 1:2 parallel balanced nearest neighbour 
matching without replacement and with a calliper of 
0.05.32 In the matched cohorts, 30-day mortality was 
modelled using Cox regression.
statistics
The absolute risk of event in patients with suspected 
poisoning was calculated overall, for those with QTc 
prolongation and for those without QTc prolongation. 
In the propensity score matched cohort, the risk associ-
ated with QTc prolongation was estimated as HRs. We 
estimated 95% CIs based on a binominal distribution. 
To illustrate the impact of QTc prolongation on 30-day 
all-cause mortality or cardiac arrest, we generated a 
Kaplan-Meier failure curve.
In a sensitivity analysis, we restricted the material to 
individuals who were both suspected of being poisoned 
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on arrival and received a discharge diagnose of poisoning. 
The prevalence of QTc prolongation and the propensity 
score analyses were repeated using the Bazett formula for 
QT correction.33
Statistical analyses were performed using STATA V.14.
The study was approved by the Danish Data Protec-
tion Agency (no. 2008-58-0035, journal nr. 15/21632) 
and The Danish Health Authority (no. 3-3013-1031).
Patient and public involvement
This was a study without contact to patients. All informa-
tion was obtained through registers.
results
Characteristics of the study cohort
At the four hospitals, we identified a total of 6838 ED 
contacts with suspected poisoning. After exclusion of 
those aged <18 years (n=22), an ECG not recorded in 
an acceptable time-interval (n=1411), multiple contacts 
within the study period (n=1412), a missing QT interval 
(n=1) or QRS duration ≥120 ms (n=123), the final 
cohort comprised 3869 patients with suspected poisoning 
(48.0% men, median age 38) (figure 1). Of these, 69.2% 
(n=2676) had a discharge diagnose of poisoning.
Patients with a prolonged QTc interval were older, had 
more comorbidity and more commonly had a history 
of heart disease than those without QTc prolongation 
(table 1).
In addition, prescription of QT-prolonging drugs was 
more frequent in the group with a prolonged QTc interval. 
Among patients with a redeemed prescription of a single 
QT-prolonging drug, 7.5% had a prolonged QTc interval, 
whereas 8.8% of those taken two or more QT-prolonging 
drugs had a prolonged QTc interval. Among the included 
Figure 1 Flow chart of the study population. ED, emergency department; QTc interval, corrected QT interval.
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patients, 6.5% (95% CI 5.9 to 7.4) had QTc prolongation, 
while the prevalence of severe QTc prolongation (≥500 
ms) was 0.7% (95% CI 0.5 to 1.0). The prevalence of QTc 
prolongation in relation to specific groups of poisoning 
varied within the range 4.8%–6.2%, with the highest prev-
alence in the group categorised as ‘others’ (6.2%; 95% CI 
4.8 to 8.7) (table 2).
Prognosis
Overall, the 30-day risk of all-cause mortality or cardiac 
arrest was 0.8% (95% CI 0.6% to 1.2%, n=32). Among 
individuals with QTc prolongation (n=253), death within 
30 days after contact to the ED occurred in seven patients, 
whereas one patient suffered from cardiac arrest. Among 
those with a normal QTc interval (n=3616), we found 24 
Table 1 Baseline characteristics of the study population
All*
Before propensity score 
matching After propensity score matching
QTc Prolonged QTc QTc Prolonged QTc
<440 ms (men 
and women) 
≥450 ms (men)
≥460 ms 
(women) 
<440 ms (men 
and women) 
≥450 ms (men) 
≥460 ms (women) 
N 3869 3296 253 496 248
Sex 
Male (%) 1859 (48.0) 1634 (49.6) 121 (47.8) 229 (46.2) 119 (48.0) 
Age (median, IQR) 38 (25–53) 36 (24–51) 52 (36–68) 53 (37–69) 51 (35–66)
  18–50, n (%) 2747 (71.0) 2444 (74.2) 119 (47.0) 236 (48.0) 119 (48.0)
  51–69, n (%) 788 (20.4) 611 (18.5) 77 (30.4) 140 (28.5) 77 (31.0)
  ≥70, n (%) 334 (8.6) 241 (7.3) 57 (22.5) 116 (23.6) 52 (21.0)
Charlson Comorbidity Index, n (%)
  CCI=0 2747 (71.0) 2395 (72.7) 140 (55.3) 263 (53.0) 140 (56.5)
  CCI=1 718 (18.6) 587 (17.8) 60 (23.7) 133 (26.8) 58 (23.4)
  CCI≥2 404 (10.4) 314 (9.5) 53 (20.9) 100 (20.2) 50 (20.2)
Myocardial infarction or congestive 
heart failure, n (%)
185 (4.8) 136 (4.1) 32 (12.6) 55 (11.1) 29 (11.7)
QT-prolonging drugs, n (%) 1518 (39.2) 1248 (37.9) 110 (43.5) 213 (42.9) 109 (44.0)
ECG measurements
  Heart rate (median, IQR) 85 (73–99) 87 (74–101) 76 (65–84) 76 (65–87) 76 (65–85)
  QTc ≥500 ms, n (%) 27 (0.7) – 27 (10.7) – 27 (10.9)
Any diagnose of poisoning, n (%) 2676 (69.2) 2282 (69.2) 153 (60.5) 310 (62.5) 151 (60.9)
Group of poisoning, n (%)
  1. Analgesics and drugs of abuse 397 (14.8) 333 (14.6) 21 (13.7) 41 (13.2) 21 (13.9)
  2. Psychotropic drugs and drugs 
affecting the central nervous 
system
805 (30.1) 695 (30.5) 49 (32.0) 103 (33.2) 49 (32.5)
  3. Organic and chemical 
substances, non-medical
502 (18.8) 437 (19.1) 24 (15.7) 50 (16.1) 24 (15.9)
  4. Others 470 (17.6) 392 (17.2) 30 (19.6) 54 (17.4) 29 (19.2)
  5. Multidrug 502 (18.8) 425 (18.6) 29 (19.0) 62 (20.0) 28 (18.5)
Clinics, n (%)
  The University Hospital Skåne, 
Lund
1794 (46.4) 1539 (46.7) 125 (49.4) 247 (49.8) 124 (50.0)
  Odense University Hospital 501 (12.9) 419 (12.7) 28 (11.1) 50 (10.1) 28 (11.3)
  Helsingborg Hospital 1372 (35.5) 1176 (35.7) 81 (32.0) 170 (34.3) 79 (31.9)
  Hospital of South West Jutland 202 (5.2) 162 (4.9) 19 (7.5) 29 (5.8) 17 (6.9)
*In the total cohort patients with a near-overlapping QTc interval (440–449 ms men, 440–459 ms women) are included (n=320).
CCI, Charlson Comorbidity Index.
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events during the follow-up period. The absolute risk of 
event within 30 days was 3.2% (95% CI 1.4 to 6.1) and 
0.7% (95% CI 0.5 to 1.0) for patients with and without 
QTc prolongation, respectively.
The propensity score analysis included 248 patients with 
a QTc of ≥450 ms (men) or ≥460 ms (women) matched 
with 496 patients with a QTc interval <440 ms. Acceptable 
balance of baseline variables was achieved (table 1). QTc 
prolongation was associated with a HR of 3.6 (95% CI 1.0 
to 12.2) for 30-day all-cause mortality or cardiac arrest 
(table 3 and figure 2).
subgroups and sensitivity analyses
Our results from the subgroup analysis are outlined 
in online supplementary appendix D. When restricting to 
those who also received a discharge diagnose of poisoning, 
we found an overall 30-day risk of 0.7% (95% CI 0.4 to 
1.1), and QTc prolongation yielded an overall HR of 10.5 
(95% CI 1.2 to 90.0). When we corrected the QT interval 
with the Bazett formula, a total of 1112 patients had QTc 
prolongation (28.7%), which was associated with a HR of 
1.0 (95% CI 0.2 to 5.5).
dIsCussIOn
In this transnational cohort of patients with suspected 
poisoning arriving to the ED, QTc prolongation was 
common (6.5%). A prolonged QTc interval was associ-
ated with a threefold increased risk of 30-day all-cause 
mortality or cardiac arrest and an absolute risk of 3.2%.
This study has several strengths. First, this was a multi-
centre cohort study with data from two Swedish and two 
Danish EDs, which ensured a broad representability. Use 
of personal identification numbers in all contacts to the 
hospital system in Sweden and Denmark provides the possi-
bility to follow individual patients in and out of hospital, 
and loss of follow-up or unmeasured registration of death 
did not occur.17–22 In addition, we implemented several 
Table 2 QTc prolongation in relation to poisoning groups
Analgesics and 
drugs of abuse
Psychotropic drugs 
including drugs 
affecting the central 
nervous system
Chemical and 
biological 
substances, non-
medical Others Multidrug
ICD-10 codes or 
definition
T39-T40, F110, 
F120, F140, F150, 
F160
T42-T44, F130, F190 T51-T65, F100, 
F170, F180
T36-T38, T41, 
T45-T50
≥2 of the described 
poisoning groups
N 397 805 502 470 502
QTc prolongation, 
n (%; 95% CI)
≥450 ms (men)
≥460 ms (women)
21 (5.3; 3.3 to 8.0) 49 (6.1; 4.5 to 8.0) 24 (4.8; 3.1 to 7.0) 29 (6.2; 4.2 to 8.7) 28 (5.6; 3.7 to 8.0)
ICD-10, International Classification of Diseases, 10th Revision.
Table 3 Risk assessment in the study population  
Propensity score matched cohort
n
Events 
(no.) HR* (95% CI)
Suspected poisoning
  Normal QTc interval
  <440 ms
496 n<5 1.0 (ref) 
  QTc prolongation 
  ≥450 ms,  men
  ≥460 ms, women 
248 8 3.6 (1.0 to 12.2)
Diagnose of poisoning†
  Normal QTc interval 
  <440 ms 
310 n<5 1.0 (ref)
  QTc prolongation
  ≥450 ms, men
  ≥460 ms, women
151 6 10.5 (1.2 to 90.0)
*Cox regression calculated after 1:2 propensity score matching 
comparing patients with QTc prolongation to patients without 
QTc prolongation. In this population, patients with near-
overlapping ranges of the QTc interval were excluded (QTc 
440–449 ms, men and 440–459 ms, women).
†Patient who arrived with suspected poisoning and had a 
discharge diagnose of poisoning.
If the number of events in the analysis was less than 5 (marked 
by n<5), the number of patients in the strata is not shown.
Figure 2 Kaplan-Meier failure estimate. QTclong=0, patients 
without QTc prolongation; QTclong=1, patients with QTc 
prolongation.
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confounders in our propensity score model, and thus 
managed to control for these despite a low event rate. We 
included patients who were suspected for being poisoned 
on arrival to the ED. These patients do—in contrast to 
patients identified by their discharge diagnosis—represent 
the clinical situation at the door in the ED. At this point, 
the doctors have to decide whether to observe the patients 
using telemetry.
This study also has several limitations. First of all, the 
design was an observational design. The ECG measures 
were all automatic readouts, and we did not manu-
ally validate the length of the QT intervals. However, 
this method has been validated in a previous Danish 
study using the same technique, which showed a good 
overall agreement between manual QTc interval and 
the digital record of the QTc interval with a mean 
difference of 1.3 ms.8 Furthermore, we did not exclude 
ECGs with diagnoses complicating QTc measuring, for 
example, atrial fibrillation. We did not have informa-
tion regarding previous ECGs, and we do not know if 
some patients had a previous ECG with QTc prolonga-
tion before arrival with suspected poisoning. The dose of 
drug or substance was unknown, and we were ignorant 
of the timing of the ECG recording in relation to peak 
drug concentration. The poisonings were not confirmed 
by blood samples or by urine tests but were extracted 
from predefined ICD-10 codes. In addition, adminis-
tration of diuretics and possible electrolyte imbalance 
were unknown.
The small number of events was a limitation in its 
own and did not allow for meaningful subgroup anal-
ysis. Since cardiac arrest was identified based on hospital 
registration, an eventually event of unregistered cardiac 
arrest, where the patient survived, is not included as an 
event. The number of these events is believed to be small 
as registration of cardiac arrest is mandatory in both the 
Swedish and Danish healthcare system. With a small 
number of events, any miscounting of events would lead 
to considerable change in risk estimates. If we have over-
looked one event of cardiac arrest who survived in the 
group of patients with QTc prolongation, it would increase 
the absolute risk from 3.2% to 3.6%, while the risk of 
event in the entire study population would increase from 
0.8% to 0.9%.
The event rate in our cohort (0.8%) is in accordance with 
previous studies of poisoned patients (0.5%–1.2%).16 34 35 
In contrast, the prevalence of QTc prolongation is substan-
tially lower (6.5%) than in a previous study of unselected 
ED patients (35%).36 This is probably due to the choice 
of QT correcting formula. If the Bazett formula had been 
chosen for main analysis, the prevalence of QTc prolonga-
tion in our study population would have been 28.7%. It is of 
broad consensus that the more widely used Bazett formula 
tends to overcorrect at heart rates at 80–90 beats per minute 
and above resulting in a higher prevalence of QTc prolon-
gation.33 37 As a high percentage of acute patients have 
tachycardia at arrival, this probably explains most of the 
difference between the occurrence of QTc prolongation in 
our study and in the study of unselected ED patients. The 
Framingham formula used in our study is considered supe-
rior compared with the more widely used Bazett formula.37
The clinical impact of our findings is the difference in 
risk of all-cause mortality and cardiac arrest within 30 days 
in respect to QTc prolongation. We found an absolute 
risk of 0.7% in patients with suspected poisoning without 
QTc prolongation, whereas patients with a prolonged QTc 
interval have an absolute risk of 3.2%, which translates into 
an HR of 3.6 (95% CI 1.0 to 12.2). In the general popula-
tion, a meta-analysis reported a pooled relative risk of 1.35 
(95% CI 1.24 to 1.46) for long-term mortality in patients 
with QTc prolongation.7 A recent study including all 
patients who had an ECG recorded at the hospital for any 
reason reported QTc prolongation to be associated with 
a HR of 7.3 (95% CI 4.10 to 13.05) for 30-day mortality.37 
Combined, these studies support the hypothesis that 
patients with a prolonged QTc are at increased risk. Whether 
this is directly linked to the increased QTc interval or due to 
other risk factors associated with a prolonged QTc remains 
unknown.
As demonstrated in our cohort, the prevalence of 
QTc prolongation is strongly associated to the correc-
tion formula. Furthermore, the difference between the 
HR calculated in the main analysis using Framingham 
(HR 3.6; 95% CI 1.0 to 12.2) versus the sensitivity anal-
ysis using Bazett (HR 1.0; 95% CI 0.2 to 5.5) is remark-
able. We suspect that using the Bazett formula dilutes 
the association by including more patients at low risk as 
a result of overcorrection.
Despite the use of a propensity score model adjusting 
for several covariates, we cannot exclude residual 
confounding. From a clinical point of view, this means 
that the patients with a prolonged QTc probably need 
special care and attention. However, the needed care 
is not necessarily limited to telemetry and increased 
cardiac awareness. Of note, a ventricular arrhythmia 
with fatal outcome caused by drug-induced QTc prolon-
gation would be expected to happen within a relatively 
short time-interval after exposure. This was not the 
case in our study with the first event occurring 3 days 
after contact (see figure 2). In addition, a QTc interval 
threshold for identification of patients in need of 
cardiac telemetry is not well established. Unfortunately, 
our cohort was too small to do further subdivisions of 
the QTc interval.
Ventricular arrhythmias, especially torsades de pointes, 
are feared consequences of QT prolongation and may be 
the cause of death in some poisonings.38 39 However, as 
torsades de pointes is a rare condition,38 39 it is unlikely to 
have influenced our results.
In this cohort of patients with suspected poisoning, 
69.2% received a discharge diagnose of poisoning. 
This is in contrast to results from a previous Danish 
study, which found an agreement of 79% for suspected 
poisoning on arrival and a discharge diagnose of 
poisoning.17 In our cohort, only those who had an 
ECG recorded were included, and several common 
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poisonings, for example, alcohol intoxication, are 
usually not followed by ECG recording.
QTc prolongation was most frequent in the group of 
poisoning labelled ‘others’ (table 2). In this group, the 
ICD-10 code T50.9 for unspecific poisonings was given to 
the majority of the patients. These patients might have 
been too sick to tell about their poisoning or perhaps 
denied to do so. This reflects a common clinical problem in 
the ED and indicates that a specific poisoning diagnosis can 
be difficult to establish. Furthermore, lack of precision in 
coding procedure may contribute to unspecific diagnoses.
In conclusion, we found QTc prolongation in a 
mixed population of patients with suspected poisoning 
in the ED of two Swedish and two Danish hospi-
tals to be associated with a threefold risk of 30-day 
all-cause mortality or cardiac arrest and an absolute 
risk of 3.2%.
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